Non-crystalline light chain proximal tubulopathy associated with monoclonal gammopathy of renal significance: A case report and review of the literature

医学 肾小管病变 肾活检 蛋白尿 多发性骨髓瘤 不确定意义的单克隆抗体病 范科尼综合征 肾病 活检 化疗 内科学 硼替佐米 病理 单克隆 内分泌学 免疫学 抗体 单克隆抗体 糖尿病
作者
Fengqin Li,Xinmiao Xie,Linlin Sun,Zhigang Zhang,Jie Chen,Xiaoxia Wang
出处
期刊:Clinical Nephrology [Dustri-Verlag Dr. Karl Feistle]
卷期号:99 (1): 32-40
标识
DOI:10.5414/cn110883
摘要

Light chain proximal tubulopathy (LCPT) is a rare M-proteinemia-related nephropathy. Non-crystalline LCPT is even rarer. We herein report an unusual case of renal dysfunction and proteinuria due to κ-restricted and non-crystalline LCPT in a context of monoclonal gammopathy of renal significance (MGRS) without Fanconi syndrome (FS).A 67-year-old man was admitted for a 2-year history of proteinuria and renal dysfunction. Fanconi syndrome (FS) was not observed. He was noted to have IgG-κ M protein, and the previous bone marrow biopsy revealed that atypical plasma cells accounted for 1.5% of the cells, which did not meet the diagnostic criteria for multiple myeloma. A renal biopsy revealed proximal tubular injury, including increased lysosomes with irregular contours and a mottled appearance without crystalline structure and the accumulation of κ light chains. He was diagnosed with non-crystalline LCPT with MGRS. Concurrently, we reviewed the non-crystalline LCPT cases previously published in the literature. Our patient finally received chemotherapy with a bortezomib and dexamethasone regimen. The patient did not seem to achieve evident nephrological and hematological remission after chemotherapy, but he was in a stable condition.Very few similar cases are reported in the literature. It is considered crucial to enhance our knowledge about these cases to establish the definition of the non-crystalline LCPT entity and allow for early diagnosis. Chemotherapy may not be necessary for all patients to maintain good renal function. Future prospective clinical research studies are necessary.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
轻松的小虾米关注了科研通微信公众号
刚刚
SciGPT应助宋嘉新采纳,获得10
刚刚
买尔孜亚发布了新的文献求助10
1秒前
李白发布了新的文献求助10
2秒前
落后藏鸟完成签到,获得积分10
2秒前
3秒前
3秒前
洛花羽落完成签到,获得积分10
3秒前
Akim应助科研通管家采纳,获得10
3秒前
顺利的伊应助科研通管家采纳,获得10
4秒前
科研通AI2S应助科研通管家采纳,获得10
4秒前
陈军应助科研通管家采纳,获得10
4秒前
充电宝应助科研通管家采纳,获得10
4秒前
SciGPT应助科研通管家采纳,获得30
4秒前
丘比特应助科研通管家采纳,获得10
4秒前
Hello应助科研通管家采纳,获得10
4秒前
4秒前
Ava应助科研通管家采纳,获得10
4秒前
陈军应助科研通管家采纳,获得10
5秒前
哈哈应助柚子采纳,获得10
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
JamesPei应助科研通管家采纳,获得10
5秒前
陈军应助科研通管家采纳,获得10
5秒前
寻道图强应助科研通管家采纳,获得30
5秒前
传奇3应助科研通管家采纳,获得10
5秒前
bkagyin应助科研通管家采纳,获得10
5秒前
清风完成签到 ,获得积分10
5秒前
小K发布了新的文献求助10
5秒前
otmm完成签到,获得积分10
5秒前
深情安青应助科研通管家采纳,获得10
5秒前
wanci应助科研通管家采纳,获得10
5秒前
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
5秒前
科研通AI2S应助科研通管家采纳,获得10
5秒前
余宁完成签到 ,获得积分10
6秒前
6秒前
yoru16发布了新的文献求助10
6秒前
6秒前
高分求助中
Evolution 10000
Sustainability in Tides Chemistry 2800
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
Diagnostic immunohistochemistry : theranostic and genomic applications 6th Edition 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3156402
求助须知:如何正确求助?哪些是违规求助? 2807851
关于积分的说明 7874906
捐赠科研通 2466107
什么是DOI,文献DOI怎么找? 1312627
科研通“疑难数据库(出版商)”最低求助积分说明 630194
版权声明 601912